翔豐華(300890.SZ):就建年產能6萬噸高端人造石墨負極材料一體化項目的公司已註冊成立
格隆匯6月25日丨翔豐華(300890.SZ)公佈,此前披露,公司於2021年6月7日、2021年6月23日分別召開第二屆董事會第九次會議和2021年第一次臨時股東大會,審議通過了《關於公司與蓬溪縣政府簽署《投資協議》暨對外投資的議案》,同意公司在四川省遂寧市蓬溪縣建設年產能6萬噸高端人造石墨負極材料一體化生產基地建設項目。
2021年6月24日,項目公司已完成工商註冊登記,並取得蓬溪縣行政審批局頒發的《營業執照》,名稱為四川翔豐華新能源材料有限公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.